key: cord-0890264-y0wu60n4
authors: Patterson, E.I.; Elia, G.; Grassi, A.; Giordano, A.; Desario, C.; Medardo, M.; Smith, S.L.; Anderson, E.R.; Prince, T.; Patterson, G.T.; Lorusso, E.; Lucente, M.S.; Lanave, G.; Lauzi, S.; Bonfanti, U.; Stranieri, A.; Martella, V.; Basano, F. Solari; Barrs, V.R.; Radford, A.D.; Agrimi, U.; Hughes, G. L.; Paltrinieri, S.; Decaro, N.
title: Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy
date: 2020-07-23
journal: bioRxiv
DOI: 10.1101/2020.07.21.214346
sha: cd8d434ad2e3913ccc6d3443da65f7b9d2c98e33
doc_id: 890264
cord_uid: y0wu60n4

SARS-CoV-2 originated in animals and is now easily transmitted between people. Sporadic detection of natural cases in animals alongside successful experimental infections of pets, such as cats, ferrets and dogs, raises questions about the susceptibility of animals under natural conditions of pet ownership. Here we report a large-scale study to assess SARS-CoV-2 infection in 817 companion animals living in northern Italy, sampled at a time of frequent human infection. No animals tested PCR positive. However, 3.4% of dogs and 3.9% of cats had measurable SARS-CoV-2 neutralizing antibody titers, with dogs from COVID-19 positive households being significantly more likely to test positive than those from COVID-19 negative households. Understanding risk factors associated with this and their potential to infect other species requires urgent investigation. One Sentence Summary SARS-CoV-2 antibodies in pets from Italy.

humans (2), and rapidly spread worldwide becoming a pandemic (3). Although the virus is 43 believed to spread almost exclusively by human-to-human transmission, there are concerns that 44 some animal species may contribute to the ongoing SARS-CoV-2 pandemic epidemiology (4). 45 To date, sporadic cases of SARS-CoV-2 infection have been reported in dogs and cats. These 46 include detection of SARS-CoV-2 RNA in respiratory and/or fecal specimens of dogs and cats 47 with or without clinical signs (5-7), as well as of specific antibodies in sera from pets from 48 coronavirus disease 2019 (COVID-19) affected areas (7, 8) . In addition, experimental infection of 49 various animal species has demonstrated that while dogs appear poorly susceptible to SARS- 50 CoV-2 infection, developing asymptomatic infections and shedding low-titer or no virus, cats 51 develop respiratory pathology and shed high titers of SARS-CoV-2, even being able to infect in-52 contact animals (9,10). Wide scale testing of susceptible species is needed to assess the extent of 53 animal infection under more natural conditions of husbandry. Here, we conducted an extensive 54 epidemiological survey from March to May 2020 in cats and dogs living in Italy, either in 55 SARS-CoV-2 positive households or living in geographic areas that were severely affected by 56 COVID-19. To our knowledge, this is the largest study to investigate SARS-CoV-2 in 57 companion animals to date. 58 All animals were sampled by their private veterinary surgeon during routine healthcare visits. 59 Sampling of animals for this study was approved by the For 340 dogs and 188 cats, full signalment and clinical history were available, including   66   breed, sex, age, exposure to COVID-19 infected humans (COVID-19 positive household,   67   suspected COVID-19 positive household but not confirmed by specific assay, and COVID-19   68 negative household), presence of respiratory signs (cough, sneezing, conjunctivitis, nasal and/or 69 ocular discharge). 70 Sera were available for 188 dogs and 63 cats for which complete signalment, history and location 71 were available (Fig. 1) . Additional sera were collected from diagnostic laboratories for 200 dogs 72 and 89 cats from the affected areas, but which lacked further historical information. 73 Detection of SARS-CoV-2 RNA used two real-time RT-PCR assays targeting nucleoprotein and 74 envelope protein genes as previously described (11). Plaque reduction neutralization tests 75 (PRNT) were using a previously established protocol (8) with SARS-CoV-76 2/human/Liverpool/REMRQ0001/2020 isolate was cultured as previously described (9). (1.5%) and 1 of 38 cats (2.6%) from COVID-19 negative households (Table 1) . For those 423 89 animals where an age was recorded, 0 of 30 aged less than 1 year (0%), 6 of 92 aged 1-3 years 90 (6.5%), 3 of 102 aged 4-7 years (2.9%) and 6 of 199 aged 8 and over (3.0%) tested positive. 91 None of the animals with neutralizing antibodies displayed respiratory symptoms at the time of 92 sampling. 93 Reference sera or ascitic fluids from animals previously shown to be positive for canine enteric 94 coronavirus (14) , canine respiratory coronavirus (15) and feline coronavirus (16) tested negative 95 by the PRNT assay for SARS-CoV-2, confirming the specificity of the obtained results (8). 

The SARS-CoV-2/human/Liverpool/REMRQ0001/2020 isolate was cultured in Vero E6 cells as previously 304 described (12). PRNTs were performed as previously described (13). Briefly, sera were heat inactivated at 56°C for 305 

Immunity after natural exposure to 203 enteric canine coronavirus does not provide complete protection against infection with 204 the new pantropic CB/05 strain

Serological and molecular evidence that canine respiratory 207 coronavirus is circulating in Italy

Discrepancies between feline coronavirus 210 antibody and nucleic acid detection in effusions of cats with suspected feline infectious 211 peritonitis